This guide indicates steps to be taken in investigating symptoms that could be breast cancer, and provides information about the triple test approach to diagnosis. This resource is an update of the 2017 publication of the same title.

https://www.canceraustralia.gov.au/system/tdf/publications/investigation-new-breast-symptom-guide-general-practitioners/pdf/investigation-of-a-new-breast-symptom-a-guide-for-general-practitioners.pdf?file=1&type=node&id=12436

This information is for women who have been treated for early breast cancer or ductal carcinoma in situ (DCIS) and their carers. It provides information about shared follow-up and survivorship care, including the benefits of shared care and who is involved.

https://www.canceraustralia.gov.au/system/tdf/publications/information-women-shared-follow-and-survivorship-care-early-breast-cancer/pdf/scbcw_information_for_women.pdf?file=1&type=node&id=12311

This document contains the 200 recommendations and practice points that comprise the Guidance for the management of early breast cancer. The Guidance has been developed as an essential resource for health professionals involved in the management of women and men with breast cancer. It updates and replaces in full or in part Cancer Australia’s 2001 Clinical Practice Gguidelines for the management of breast cancer in women and various subsequent topic-specific updates.

This Guidance has been developed to meet the need for comprehensive, up-to-date, evidence-based guidance that encompasses management of early breast cancer from the point of diagnosis.

The Guidance is also presented in a user-friendly, accessible format on a Cancer Australia featured site at www.guidancebreastcancer.gov.au.

https://www.canceraustralia.gov.au/system/tdf/publications/guidance-management-early-breast-cancer-recommendations-and-practice-points/pdf/guidance_for_the_management_of_early_breast_cancer_recommendations_and_pps_2020_0.pdf?file=1&type=node&id=12303

This reportdescribes the approach taken to develop the Guidance for the Managment of the early breast cancer.

https://www.canceraustralia.gov.au/system/tdf/publications/guidance-management-early-breast-cancer-methods/pdf/guidance_for_the_management_of_early_breast_cancer_methods_2020.pdf?file=1&type=node&id=12301

Cancer Australia develops position statements using the best available evidence to provide national leadership and direction on issues with an impact on cancer, which are of clinical significance, emerging in cancer control, or of significant community interest.

https://www.canceraustralia.gov.au/system/tdf/publications/position-statement-use-fine-needle-aspiration-fna-and-core-biopsy-breast-breastscreen-australia/pdf/position_statement_on_the_use_of_fna_and_core_biopsy_of_the_breast_in_the_breastscreen_australia_program.pdf?file=1&type=node&id=11801

The use of biopsy techniques for the assessment of mammographic screening-detected lesions varies across the BreastScreen Australia program. In this context, there is uncertainty about the appropriate use and limitations of non-excisional biopsy techniques. Accurate biopsy information is essential to the BreastScreen Australia Program, as women with screen-detected lesions and their health professionals make decisions on their management options using this information.

https://www.canceraustralia.gov.au/system/tdf/publications/high-level-review-evidence-and-guidelines-inform-position-statement-use-fine-needle-aspiration-fna/pdf/high_level_review_of_evidence_and_guidelines_to_inform_position_statement_fna_core_biopsy.pdf?file=1&type=node&id=11796

https://www.canceraustralia.gov.au/system/tdf/publications/shared-care-summary/pdf/shared_care_summary.pdf?file=1&type=node&id=11326